Agilent Technologies (NYSE:A – Get Free Report) posted its quarterly earnings results on Monday. The medical research company reported $1.38 EPS for the quarter, topping the consensus estimate of $1.34 by $0.04, MarketWatch Earnings reports. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 16.20% and a return on equity of 29.86%. The company’s quarterly revenue was down 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.53 earnings per share.
Agilent Technologies Trading Up 0.7 %
NYSE A opened at $113.98 on Tuesday. The stock has a market capitalization of $33.35 billion, a P/E ratio of 29.84, a P/E/G ratio of 2.01 and a beta of 1.04. Agilent Technologies has a 52-week low of $96.80 and a 52-week high of $160.26. The firm has a 50-day moving average price of $109.98 and a 200 day moving average price of $117.66. The company has a quick ratio of 1.68, a current ratio of 2.29 and a debt-to-equity ratio of 0.49.
Agilent Technologies Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.83%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio is presently 24.61%.
Analysts Set New Price Targets
Insider Buying and Selling
In related news, VP Rodney Gonsalves sold 3,500 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $118.78, for a total transaction of $415,730.00. Following the completion of the transaction, the vice president now directly owns 24,219 shares of the company’s stock, valued at $2,876,732.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.31% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in A. Synovus Financial Corp increased its holdings in Agilent Technologies by 2.3% in the first quarter. Synovus Financial Corp now owns 6,751 shares of the medical research company’s stock valued at $895,000 after buying an additional 153 shares in the last quarter. Blair William & Co. IL grew its position in shares of Agilent Technologies by 7.3% in the first quarter. Blair William & Co. IL now owns 28,606 shares of the medical research company’s stock valued at $3,785,000 after purchasing an additional 1,957 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Agilent Technologies by 52.1% in the first quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company’s stock valued at $309,000 after purchasing an additional 799 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Agilent Technologies by 1.1% in the first quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock valued at $3,246,209,000 after purchasing an additional 261,435 shares during the last quarter. Finally, Zions Bancorporation N.A. grew its position in shares of Agilent Technologies by 10.8% in the first quarter. Zions Bancorporation N.A. now owns 2,880 shares of the medical research company’s stock valued at $381,000 after purchasing an additional 281 shares during the last quarter. 85.42% of the stock is owned by hedge funds and other institutional investors.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Five stocks we like better than Agilent Technologies
- The 3 Best Retail Stocks to Shop for in August
- Safeguard your portfolio with these three bargain stocks
- What Does a Stock Split Mean?
- Membership clubs gain leverage for the consumer rebound
- Pros And Cons Of Monthly Dividend Stocks
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.